EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019–Related Hospitalizations in Georgia

Ana Aslanikashvili iD, Charlotta Rylander iD, Tinatin Manjavidze iD, Amiran Gamkrelidze iD, Davit Baliashvili iD, Erik Eik Anda iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Ana Aslanikashvili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: COVID-19, Hospitalization, Hepatitis C, SARS-CoV-2. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, University of Tromsø-The Arctic University of Norway, University of Tromsø—The Arctic University of Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to evaluate the impact of hepatitis C virus (HCV) infection and treatment status on coronavirus disease 2019 (COVID-19)–related hospitalizations in Georgia.

Methods

We analyzed 2020–2021 Georgian health registry data for COVID-19–positive individuals and categorized the data by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations.

Results

Treated individuals with HCV had lower odds of COVID-19–related hospitalization compared to anti-HCV-negative individuals, while untreated HCV-viremic and anti-HCV-positive nonviremic individuals had higher odds.

Conclusions

HCV treatment prior to COVID-19 infection was associated with lower odds of COVID-19–related hospitalization, highlighting the benefits of HCV management in the context of the pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HospitalizationHepatitis CSARS-CoV-2HumansMaleFemaleMiddle AgedGeorgia (Republic)AdultAgedAntiviral AgentsHepacivirusYoung AdultAdolescentGeorgia

Stichwörter der Autor:innen

COVID-19Georgiadirect-acting antiviralshepatitis C virusregistry study

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
  • Department of Medical Statistics, National Center for Disease Control and Public Health Georgia, Tbilisi, Georgia.
  • School of Health Sciences, University of Georgia, Tbilisi, Georgia.
  • Task Force for Global Health, Tbilisi, Georgia.

ORCID-Profile: Ana Aslanikashvili, Charlotta Rylander, Tinatin Manjavidze, Amiran Gamkrelidze, Davit Baliashvili, Erik Eik Anda

Förderung

  • FIC NIH HHS
  • University of Tromsø-The Arctic University of Norway
  • University of Tromsø—The Arctic University of Norway

Zitieren

APA

Aslanikashvili, A., Rylander, C., Manjavidze, T., Gamkrelidze, A., Baliashvili, D., & Anda, E. E. (2024). Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019–Related Hospitalizations in Georgia. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae103

Vancouver

Aslanikashvili A, Rylander C, Manjavidze T, Gamkrelidze A, Baliashvili D, Anda EE. Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019–Related Hospitalizations in Georgia. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae103

BibTeX
@article{Aslanikashvili2024,
  author = {Aslanikashvili, Ana and Rylander, Charlotta and Manjavidze, Tinatin and Gamkrelidze, Amiran and Baliashvili, Davit and Anda, Erik Eik},
  title = {Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019–Related Hospitalizations in Georgia},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae103}
}
Kostenlos starten →